International Conference on Cancer Genetics and Molecular Oncology
(ICCGMO-26)

21st November 2026 || Bhubaneswar - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Cancer Genetics and Molecular Oncology (ICCGMO), scheduled to be held on 21st November 2026 in Bhubaneswar, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Genetics.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Cancer Genomics
    This track will explore the latest breakthroughs in cancer genomics, focusing on the identification and characterization of somatic mutations. Discussions will include the implications of genomic profiling for precision oncology and personalized medicine. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Oncogenes and Tumor Suppressor Genes
    This session will delve into the roles of oncogenes and tumor suppressor genes in cancer development and progression. Researchers will present findings on how these genetic factors contribute to tumorigenesis and therapeutic resistance. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Cancer Biomarkers: Discovery and Application
    This track will highlight the discovery of novel cancer biomarkers and their applications in early detection and treatment monitoring. Emphasis will be placed on the integration of biomarker research into clinical practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Epigenetic Alterations in Cancer
    This session will focus on the role of epigenetic modifications in cancer biology, including DNA methylation and histone modification patterns. Researchers will discuss how these alterations influence gene expression and tumor behavior. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Targeted Therapies in Oncology
    This track will examine the development and implementation of targeted therapies in cancer treatment. Presentations will cover the mechanisms of action, efficacy, and challenges associated with these innovative therapeutic approaches. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Molecular Diagnostics in Cancer Care
    This session will address the advancements in molecular diagnostics for cancer, including mutation screening and genomic profiling techniques. The focus will be on how these diagnostics enhance patient stratification and treatment outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Cancer Pathways and Therapeutic Targets
    This track will explore the intricate cancer pathways that drive tumorigenesis and metastasis. Discussions will include identifying novel therapeutic targets within these pathways for the development of new treatment strategies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Genomic Instability and Cancer Progression
    This session will investigate the mechanisms of genomic instability and its contribution to cancer progression. Researchers will present data on how instability affects tumor evolution and response to therapy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Gene Expression Analysis in Oncology
    This track will focus on the methodologies and findings related to gene expression analysis in cancer research. Emphasis will be placed on how gene expression profiles can inform treatment decisions and prognostic outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Translational Oncology: Bridging Research and Practice
    This session will highlight the importance of translational research in oncology, showcasing successful case studies that have moved from bench to bedside. Discussions will focus on overcoming barriers to effective translation of research findings into clinical applications. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 11 – Precision Oncology: Tailoring Treatments to Individuals
    This track will explore the principles and practices of precision oncology, emphasizing the need for individualized treatment strategies based on genetic and molecular profiling. Presentations will discuss the challenges and successes in implementing precision medicine in diverse patient populations. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228